All posts

Wait for a pullback before buying OpenText, this portfolio manager says

Bruce Campbell
So far in 2019, the technology sector has been a market standout, with Canadian companies like Constellation Software and Descartes Systems posting gains of 30 per cent or more. Waterloo-based software and services company OpenText (OpenText Stock Quote, Chart TSX:OTEX) has been a winner, too, rising more than 14 per cent year-to-date.

And while the stock has been a consistent gainer over the years, it’d be wise for investors to wait for a pullback before jumping in, says portfolio manager Bruce Campbell.

“It’s one of the Canadian tech companies that’s big enough and liquid enough to buy [other companies],” says Campbell of Campbell, Lee & Ross, to BNN Bloomberg on Tuesday. “They’re a serial acquirer but they’re good at it, often in Europe but in North America as well.”

“With some bumps, it has tended to go higher,” he says. “We don’t own it. We were hoping for a dip below $40. It didn’t quite get there and now it has moved a bit, so for us, we would wait for a pullback. Probably to C$45 now, not C$40, is where an entry point would be.”

OTEX has seen substantial growth over the last five years, where the stock has gone from the low C$14.00 range in early 2013 to a high of C$51.98 hit last July. OTEX is currently trading in the low C$51.00 range.

The company has kept up the pace in terms of acquisitions, closing in December on its purchase of cloud company Liaison Technologies for $310 million and then buying up legal document company Catalyst Repository Systems in January for $75 million. (All figures in US dollars unless where noted otherwise.)

OpenText’s last earnings report came on January 31 where it posted revenue of $735 million, a 0.1 per cent year-over-year increase, and Adjusted EBITDA of $308 million, a 6.1 per cent year-over-year growth rate. On earnings, analysts were expecting $0.70 per share, which the company beat with an EPS of $0.80 per share.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: otex
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

8 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

11 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

12 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

12 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago